Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 26;36(10):151.
doi: 10.1007/s11095-019-2682-8.

Assessing the Utility of In Vitro Screening Tools for Predicting Bio-Performance of Oral Peptide Delivery

Prajakta Gadgil  1 , Candice Alleyne  2 , Kung-I Feng  2 , Mengwei Hu  2 , Marian Gindy  2 , Alexei V Buevich  3 , Scott Fauty  4 , Gino Salituro  5 , Jianzhong Wen  5 , Ying Li  5 , Rebecca Nofsinger  6 , Tomi K Sawyer  7 , Nicole Buist  2
Affiliations

Assessing the Utility of In Vitro Screening Tools for Predicting Bio-Performance of Oral Peptide Delivery

Prajakta Gadgil et al. Pharm Res. .

Abstract

Purpose: In this study we evaluated the utility of in-vitro screening tools for predicting the in-vivo behavior of six cyclic peptides with different solubility and permeability properties (BCS class II and III), intended for oral delivery in presence of permeation enhancer Labrasol.

Methods: An in vitro flux assay was used to assess peptide permeation across a biomimetic, lipid-based membrane and in vivo studies in rats were used to determine oral peptide bioavailability in the presence of Labrasol.

Results: The in vitro flux was significantly increased for BCS class III peptides, while it significantly decreased or remained unchanged for BCS class II peptides with increasing Labrasol concentrations. The different flux responses were attributed to the combination of reduced effective free peptide concentration and increased membrane permeability in the presence of Labrasol. In vivo studies in male Wistar-Hans rats indicated improved oral bioavailability at different extents for all peptides in presence of Labrasol. On comparing the in vitro and in vivo data, a potential direct correlation for BCS class III peptides was seen but not for BCS class II peptides, due to lower free concentrations of peptides in this class.

Conclusion: This study assessed the utility of in vitro screening tools for selecting peptides and permeation excipients early in drug product development. Graphical Abstract Graphical Abstract and Figure 1 contains small text.Graphical Abstract text is made larger. The Figure 1 text cannot be made larger.

Keywords: flux; oral delivery; peptides; permeation enhancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26 - PubMed
    1. Int J Pharm. 2002 Oct 1;245(1-2):143-51 - PubMed
    1. Pharm Res. 2003 May;20(5):749-56 - PubMed
    1. Br J Pharmacol. 1992 Apr;105(4):783-6 - PubMed
    1. Br J Clin Pharmacol. 1992 Jan;33(1):39-43 - PubMed

LinkOut - more resources